Active, Not Recruiting
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
NCT02568267
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
- Locations
-
- Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
- Mayo Clinic Phoenix, Arizona, United States
- City of Hope Cancer Center Duarte, California, United States
- City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States